Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous β-amyloid and trimethyl-tin

European Journal of Neuroscience

Volumn 23, Issue 8, 2006, Pages 2027-2034

  Liu, Mei ^a   Sun, Anyang ^a,d   Shin, Eun Joo ^b   Liu, Xianxi ^a,e   Kim, Sang Geon ^c   Runyons, Cecil R ^a   Markesbery, William ^a   Kim, Hyoung Chun ^b   Bing, Guoying ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b Kangwon National University   (South Korea)

^c Seoul National University   (South Korea)

^d FUDAN UNIVERSITY   (China)

^e SHANDONG UNIVERSITY   (China)

Author keywords

Astrocyte; Epoxide hydrolase; Hippocampus; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; EPOXIDE HYDROLASE; MICROSOME ENZYME; TOXIN; TRIMETHYLTIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATION CORTEX; ASTROCYTE; BRAIN MICROSOME; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NERVE CELL CULTURE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; EPOXIDE HYDROLASES; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PEPTIDE FRAGMENTS; POSTMORTEM CHANGES; RATS; RATS, SPRAGUE-DAWLEY; TRIMETHYLTIN COMPOUNDS;

EID: 33645999663     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04724.x     Document Type: Article

References (40)

1. Behl C. Davis JB. Lesley R. Schubert D. 1994 Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77 817 827
2. Bertoli-Avella AM. Oostra BA. Heutink P. 2004 Chasing genes in Alzheimer's and Parkinson's disease HumGenet 114 413 438
3. Bowirrat A. Friedland RP. Farrer L. Baldwin C. Korczyn A. 2002 Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs JMolNeurosci 19 239 245
4. Carlson GA. 2003 A welcoming environment for amyloid plaques NatNeurosci 6 328 330
5. Corder EH. Saunders AM. Strittmatter WJ. Schmechel DE. Gaskell PC. Small GW. Roses AD. Haines JL. Pericak-Vance MA. 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 921 923
6. Corrigan FM. Crichton JS. Ward NI. Horrobin DF. 1992 Blood tin concentrations in Alzheimer's disease BiolPsychiatry 31 749 750
7. Corrigan FM. Reynolds GP. Ward NI. 1993 Hippocampal tin, aluminum and zinc in Alzheimer's disease Biometals 6 149 154
8. Delaere P. Duyckaerts C. He Y. Piette F. Hauw JJ. 1991 Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases Acta Neuropathol(Berl) 81 328 335
9. Ertekin-Taner N. Graff-Radford N. Younkin LH. Eckman C. Baker M. Adamson J. Ronald J. Blangero J. Hutton M. Younkin SG. 2000 Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees Science 290 2303 2304
10. Farin FM. Omiecinski CJ. 1993 Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue JToxicolEnvironHealth 40 317 335
11. Fung YK. Meade AG. Rack EP. Blotcky AJ. Claassen JP. Beatty MW. Durham T. 1996 Mercury determination in nursing home patients with Alzheimer's disease GenDent 44 74 78
12. Gaedigk A. Spielberg SP. Grant DM. 1994 Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions Pharmacogenetics 4 142 153
13. Gauthier E. Fortier I. Courchesne F. Pepin P. Mortimer J. Gauvreau D. 2000 Aluminum forms in drinking water and risk of Alzheimer's disease EnvironRes 84 234 246
14. Grant WB. Campbell A. Itzhaki RF. Savory J. 2002 The significance of environmental factors in the etiology of Alzheimer's disease JAlzheimers Dis 4 179 189
15. Greene JF. Williamson KC. Newman JW. Morisseau C. Hammock BD. 2000 Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification ArchBiochemBiophys 376 420 432
16. Hassett C. Aicher L. Sidhu JS. Omiecinski CJ. 1994 Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants HumMolGenet 3 421 428
17. Heininger K. 2000 A unifying hypothesis of Alzheimer's disease. III. Risk factors HumPsychopharmacol 15 1 70
18. Hu J. Akama KT. Krafft GA. Chromy BA. Van Eldik LJ. 1998 Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release Brain Res 785 195 206
19. Jensen M. Schroder J. Blomberg M. Engvall B. Pantel J. Ida N. Basun H. Wahlund LO. Werle E. Jauss M. Beyreuther K. Lannfelt L. Hartmann T. 1999 Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression AnnNeurol 45 504 511
20. Kessler R. Hamou MF. Albertoni M. de Tribolet N. Arand M. Van Meir EG. 2000 Identification of the putative brain tumor antigen BF7/GE2 as the (de) toxifying enzyme microsomal epoxide hydrolase Cancer Res 60 1403 1409
21. Kim SG. Jung KH. Yang WK. Kim ND. 1994 Differential expression of microsomal epoxide hydrolase gene by azole heterocycles in rats BiochemPharmacol 48 111 120
22. Lahiri DK. Sambamurti K. Bennett DA. 2004 Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease NeurobiolAging 25 651 660
23. Markesbery WR. Carney JM. 1999 Oxidative alterations in Alzheimer's disease Brain Pathol 9 133 146
24. Markesbery WR. Ehmann WD. Hossain TI. Alauddin M. 1984 Brain manganese concentrations in human aging and Alzheimer's disease Neurotoxicology 5 49 57
25. McKhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan EM. 1984 Clinical diagnosis of Alzheimer's disease. [ Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.] Neurology 34 939 944
26. Mirra SS. Hart MN. Terry RD. 1993 Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists ArchPatholLaboratory Med 117 132 144
27. Miyata M. Kudo G. Lee YH. Yang TJ. Gelboin HV. Fernandez-Salguero P. Kimura S. Gonzalez FJ. 1999 Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene JBiolChem 274 23963 23968
28. Moghaddam MF. Grant DF. Cheek JM. Greene JF. Williamson KC. Hammock BD. 1997 Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase NatMed 3 562 566
29. Naalsund LU. Allen CN. Fonnum F. 1985 Changes in neurobiological parameters in the hippocampus after exposure to trimethyltin Neurotoxicology 6 145 158
30. Omiecinski CJ. Hassett C. Hosagrahara V. 2000 Epoxide hydrolase- polymorphism and role in toxicology ToxicolLett 112-113 365 370
31. Pyles RB. 2001 The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors Herpes 8 64 68
32. Sambamurti K. Granholm AC. Kindy MS. Bhat NR. Greig NH. Lahiri DK. Mintzer JE. 2004 Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors CurrDrug Targets 5 517 528
33. Saunders AM. 2000 Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses JNeuropatholExpNeurol 59 751 758
34. Sheng JG. Griffin WS. Royston MC. Mrak RE. 1998 Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease NeuropatholApplNeurobiol 24 278 283
35. Sherrington R. Rogaev EI. Liang Y. Rogaeva EA. Levesque G. Ikeda M. Chi H. Lin C. Li G. Holman K. Tsuda T. Mar L. Poncin J-P. Bruni AC. Montesi MP. Sorbi S. Rainero I. Pinesssi L. Nee L. Chumakov I. Pollen D. Brookes A. Sanseau P. Polisky RJ. Wasco W. Da Silva HAR. Haines JI. Pericak-Vance MA. Tanzi RE. Roses AD. Fraser PE. Rommens JM. Stogeorge-Hyslop PH. 1995 Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 754 760 q23
36. Skoda RC. Demierre A. McBride OW. Gonzalez FJ. Meyer UA. 1988 Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization JBiolChem 263 1549 1554
37. Tarkowski E. Liljeroth AM. Nilsson A. Ricksten A. Davidsson P. Minthon L. Blennow K. 2000 TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD Neurology 54 2077 2081
38. Tong X. Zeng X. Zhou HM. 2000 Effects of zinc on creatine kinase: activity changes, conformational changes, and aggregation JProtein Chem 19 553 562
39. Vogel-Bindel U. Bentley P. Oesch F. 1982 Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate EurJBiochem 126 425 431
40. Whalley LJ. 2001 Early-onset Alzheimer's disease in Scotland: environmental and familial factors BrJPsychiatry Suppl 40 s53 s59